Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic
Crossref DOI link: https://doi.org/10.1007/s40801-015-0018-5
Published Online: 2015-02-18
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Johnston, Stephen S.
McMorrow, Donna
Farr, Amanda M.
Juneau, Paul
Ogale, Sarika
License valid from 2015-02-18